Skip to main content

Closed

IMVT: Immunovant, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-62.5%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio9.09×

Immunovant, Inc.

IMVTNASDAQ Global Select·USD·Closed

Immunovant, Inc.

IMVTNASDAQ·USD·Closed

$38.62

−2.18%

$38.62

−$0.86 (2.18%)

52W Range

90thpctl

Volume

0.37×avg

Mkt Cap

7.93BUSD

P/E

-13.9TTM

Div Yield

–ann

52W Range

90thpctl

Volume

0.37×avg

Market Cap

7.93BUSD

P/E Ratio

-13.9TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings